Company Overview and News
Stocks were indicated to open marginally higher on Friday, but not so much that the direction of this day looked set. U.S. equity indexes remain near all-time highs at a time that most international markets are not close to their highs. One issue that stands out to U.S. investors is that they have seen less upside from buying on market pullbacks than in prior years. Investors also need to consider how they want to have their investments positioned for the rest of 2018.
WFCNP YELP ADBE WMT WFC GLW ANGI COST GRUB DHI DNKN TRI
Rumors of a company being acquired by another often drive up the share price of the potential target. Investors sometimes get sidetracked by speculation of a deal, instead of focusing on the fundamentals of the company. Dunkin’ Brands Group (NASDAQ: DNKN) has been on just such a run recently. From the end of August until now, Dunkin' stock is up roughly 10%. Not coincidentally, this matches the timing of Coca-Cola’s (NYSE:KO) announcement that it would buy Costa Coffee for $5 billion.
DNKN KO SBUX
After a difficult 2018, investors may consider adding Starbucks (NASDAQ:SBUX) stock to their portfolio for the rest of the year. There are several long strategies in Starbucks stock that could lead to impressive profits.
SJM DNKN KHC KO SBUX MCD
Dunkin Brands (NASDAQ:DNKN) has surprised a lot of people since its IPO back in 2012. At the time, many observers felt that Dunkin was a washed up or tired brand. People weren’t buying the growth strategy that Dunkin was selling. Interest in the IPO was modest, and Dunkin stock didn’t do much initially.
DNKN THI SBUX QSR GMCR TAST
Coca-Cola (NYSE:KO) has gotten into the crowded coffee shop business by buying Costa Coffee from Whitbread plc (OTCMKTS:WTCBF). The deal was announced on Friday morning. Coca-Cola stock rose 40 cents on the move on Friday, but finished down for the day. Coca-Cola stock was up around 1% in morning trading today, exceeding $45 per share, little-changed from its close of $44.95 on Thursday.
NSRGY KDP DNKN KO SBUX GMCR
Dunkin' Brands Group, Inc.’s (DNKN - Free Report) unit Baskin-Robbins will continue its expansion in Ontario. Per the company, the expansion will primarily be concentrated in the Greater Toronto Area. Baskin-Robbins has signed 18 new store development agreements with existing as well as six new franchise groups.
Dunkin' Brands Group, Inc.’s (DNKN - Free Report) riveting growth potential lies in the company’s consistent efforts in expanding its beverage portfolio and strengthening digital capabilities. To this end, Dunkin' Donuts — the leading provider of coffee and baked goods under Dunkin’ Brands, is continuously innovating its menu offerings as well as making its mobile ordering easier for customers.
SCVL DNKN KO PAYC
2018-08-27 investorplace - 2
Researching beverage stocks to buy is a smart move because of the simple fact that the sector is largely secular. No matter how the underlying economy is performing, people still need to drink. That constant demand is a significant advantage for companies in the field.
STZ.B BUD KDP SJM CCU MNST STZ FIZZ SAM CGC TAP PRMW COT PEP DNKN WEED KHC KO SBUX DEO PZZA ABEV
Document Table of Contents
2018-07-28 seekingalpha - 1
I recently wrote about how McDonald's (NYSE:MCD) is the best dividend stock in the fast food industry. While McDonald's might be the best dividend paying fast food stock, there are others that are "buys" in my opinion. Jack In The Box (NASDAQ:JACK) has done a great job refocusing the business on what works and divesting what has been a distraction. With management focused in the right area and the large area in the United States and abroad to grow its footprint, I believe that Jack In The Box will have the ability to increase its dividend substantially.
DNKN JACK SONC APO MCD
2018-07-27 proactiveinvestors.com.au - 1
Brightcove Inc (NASDAQ:BCOV) shares sank following its second-quarter results. The cloud-services provider reported a net loss of US$0.16, lower than analyst expectations of a loss of US$0.06 per share. The software company has developed an online video hosting platform. Customers include Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM), Dunkin’ Brands Group Inc (NASDAQ:DNKN) and Oracle Corporation (NYSE:ORCL).
DFRG F RTN BCOV ESND DNKN OCLCF GM PKD ORCL
Dunkin' Brands Group, Inc. (DNKN - Free Report) reported solid results in second-quarter 2018, wherein both earnings and revenues surpassed the Zacks Consensus Estimate. Notably, the bottom line came ahead of the consensus mark for the third straight quarter.
BJRI DNKN PLAY CMG
Dunkin' Brands Group, Inc. (DNKN - Free Report) operates through its Dunkin’ Donuts and Baskin-Robbins brands that serve hot and cold coffee and baked goods, as well as hard-serve ice cream.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
as of ET